[Change of hemoglobin level: causes and consequences. Renal anemia].
Ryckelynck
Jean-Philippe
JP
Service de néphrologie, dialyse et transplantation rénale, Centre hospitalier universitaire Clemenceau, Boulevard Clemenceau, BP 95182, 14033 Caen Cedex 9, France.
D000740:Anemia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality / Q000628:therapy; D002318:Cardiovascular Diseases / Q000517:prevention & control; D003141:Communicable Diseases / Q000150:complications; D004921:Erythropoietin / Q000008:administration & dosage*; D019317:Evidence-Based Medicine; D006400:Hematocrit; D006452:Hemoglobinometry; D006454:Hemoglobins / Q000187:drug effects / Q000378:metabolism*; D006760:Hospitalization; D006801:Humans; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000379:methods; D051437:Renal Insufficiency / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D012307:Risk Factors; D016896:Treatment Outcome
D006454:Hemoglobins; D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin